Literature DB >> 35422003

Improving glycemic control in patients with type 2 diabetes mellitus through a peer support instant messaging service intervention (DiabPeerS): study protocol for a randomized controlled trial.

Elisabeth Höld1, Johanna Grüblbauer2, Martin Wiesholzer3, Daniela Wewerka-Kreimel4, Stefan Stieger5, Werner Kuschei3, Philip Kisser6, Elisabeth Gützer6, Ursula Hemetek4, Astrid Ebner-Zarl2, Jürgen Pripfl7,8.   

Abstract

BACKGROUND: Diabetes mellitus is one of the four priority non-communicable diseases worldwide. It can lead to serious long-term complications and produces significant costs. Due to the chronicle character of the disease, it requires continuous medical treatment and good therapy adherence of those suffering. Therefore, diabetes self-management education (DSME) (and support DSMES) plays a significant role to increase patient's self-management capacity and improve diabetes therapy. Research indicates that these outcomes might be difficult to maintain. Consequently, effective strategies to preserve the positive effects of DSMES are needed. Preliminary results show that peer support, which means support from a person who has experiential knowledge of a specific behavior or stressor and similar characteristics as the target population, is associated with better outcomes in terms of HbA1c, cardiovascular disease risk factors or self-efficacy at a lower cost compared to standard therapy. Peer-supported instant messaging services (IMS) approaches have significant potential for diabetes management because support can be provided easily and prompt, is inexpensive, and needs less effort to attend compared to standard therapy. The major objective of the study is to analyze the impact of a peer-supported IMS intervention in addition to a standard diabetes therapy on the glycemic control of type 2 diabetic patients.
METHODS: A total of 205 participants with type 2 diabetes mellitus will be included and randomly assigned to an intervention or control group. Both groups will receive standard therapy, but the intervention group will participate in the peer-supported IMS intervention, additionally. The duration of the intervention will last for 7 months, followed by a follow-up of 7 months. Biochemical, behavioral, and psychosocial parameters will be measured before, in the middle, and after the intervention as well as after the follow-up. DISCUSSION: Type 2 diabetes mellitus and other non-communicable diseases put healthcare systems worldwide to the test. Peer-supported IMS interventions in addition to standard therapy might be part of new and cost-effective approaches to support patients independent from time and place. TRIAL REGISTRATION: ClinicalTrials.gov NCT04797429 . Registered on 15 March 2021.
© 2022. The Author(s).

Entities:  

Keywords:  Austria; Diabetes self-management (support); Glycemic control; Instant messaging service; Peer support; Quality of life; Randomized controlled trial; Social support; Type 2 diabetes mellitus

Mesh:

Year:  2022        PMID: 35422003      PMCID: PMC9009500          DOI: 10.1186/s13063-022-06202-2

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.728


  54 in total

Review 1.  Peer support within a health care context: a concept analysis.

Authors:  Cindy-Lee Dennis
Journal:  Int J Nurs Stud       Date:  2003-03       Impact factor: 5.837

Review 2.  Personalized medicine in diabetes mellitus: current opportunities and future prospects.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

3.  Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics.

Authors:  Margaret A Powers; Joan Bardsley; Marjorie Cypress; Paulina Duker; Martha M Funnell; Amy Hess Fischl; Melinda D Maryniuk; Linda Siminerio; Eva Vivian
Journal:  Clin Diabetes       Date:  2016-04

4.  Type 2 diabetes patients educated by other patients perform at least as well as patients trained by professionals.

Authors:  Juan José Gagliardino; Viviana Arrechea; Daniel Assad; Gabriel G Gagliardino; Lorena González; Soledad Lucero; Liliana Rizzuti; Zulma Zufriategui; Charles Clark
Journal:  Diabetes Metab Res Rev       Date:  2013-01-03       Impact factor: 4.876

Review 5.  Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis.

Authors:  Xiaoqin He; Jie Li; Bin Wang; Qiuming Yao; Ling Li; Ronghua Song; Xiaohong Shi; Jin-An Zhang
Journal:  Endocrine       Date:  2016-11-12       Impact factor: 3.633

Review 6.  Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis.

Authors:  Aslak Steinsbekk; Lisbeth Ø Rygg; Monde Lisulo; Marit B Rise; Atle Fretheim
Journal:  BMC Health Serv Res       Date:  2012-07-23       Impact factor: 2.655

7.  WhatsApp Messenger as an Adjunctive Tool for Telemedicine: An Overview.

Authors:  Vincenzo Giordano; Hilton Koch; Alexandre Godoy-Santos; William Dias Belangero; Robinson Esteves Santos Pires; Pedro Labronici
Journal:  Interact J Med Res       Date:  2017-07-21

Review 8.  Social Media Use in Interventions for Diabetes: Rapid Evidence-Based Review.

Authors:  Elia Gabarron; Eirik Årsand; Rolf Wynn
Journal:  J Med Internet Res       Date:  2018-08-10       Impact factor: 5.428

9.  An integrated model to evaluate the impact of social support on improving self-management of type 2 diabetes mellitus.

Authors:  Xiaojia Wang; Linglan He; Keyu Zhu; Shanshan Zhang; Ling Xin; Weiqun Xu; Yuxiang Guan
Journal:  BMC Med Inform Decis Mak       Date:  2019-10-22       Impact factor: 2.796

10.  Comparative effectiveness of peer leaders and community health workers in diabetes self-management support: results of a randomized controlled trial.

Authors:  Tricia S Tang; Martha Funnell; Brandy Sinco; Gretchen Piatt; Gloria Palmisano; Michael S Spencer; Edith C Kieffer; Michele Heisler
Journal:  Diabetes Care       Date:  2014-04-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.